Volume : 12, Issue : 10, October – 2025
Title:
UV-SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BUDESONIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
Authors :
Bhavya KB, Chethan KS, Divya Shree MP, Sachin V
Abstract :
A new, simple, accurate, and precise first-order derivative spectroscopic method was developed and validated to estimate Budesonide in bulk and Tablet dosage form. The stock solution was prepared by weighing 100 mg of standard Budesonide in a100 ml volumetric flask with Acetonitrile. The stock solution was made to produce 1000 µg/ml with Acetonitrile. Further dilutions were prepared as per the procedure. The drug solution showed the maximum absorbance at 241 nm. The linearity was found in the concentration range of 2-12µg/ml. The correlation coefficient was found to be 0.9982. The regression equation was found to be Y=0.0318x+0.0029. The method was validated for linearity, accuracy, precision, ruggedness, robustness, LOD and LOQ. The LOD and LOQ for estimation of Budesonide were found to be 0.3009 µg/ml and 0.9119 µg/ml respectively. Recovery of Budesonide was found to be in the range of 96-131%. The proposed method was successfully applied for the quantitative determination of Budesonide in bulk and Tablet dosage forms.
Cite This Article:
Please cite this article in press Bhavya KB et al., UV-Spectrophotometric Method Development And Validation For The Estimation Of Budesonide In Bulk And Pharmaceutical Dosage Form, Indo Am. J. P. Sci, 2025; 12(10).
REFERENCES:
1. Panchal V, Vegad A, Desai R, Patel R, Patani P. DEVELOEPMENT AND VALIDATION OF STABILITY INDICATING RP-UPLC METHOD FOR DETERMINATION OF BUDESONIDE CAPSULE FORMUALTION. Pharma Science Monitor. 2018 Apr 1;9(2).
2. Kale NR, Pingle AP, Mirza JA, Dhongade GN. Development and validation of stability-indicating RP-HPLC method for simultaneous estimation of formoterol fumarate and budesonide in metered dose inhaler formulation. World J Pharm Res. 2014 Jun 20;3:1386-99.
3. PRAJAPATI PB, Marolia BP, Bodiwala KB, VADODARIYA JM, SHAH SA. Development and Validation of HPTLC Method for Simultaneous Estimation of Budesonide and Levalbuterol Hydrochloride in their Combined Pharmaceutical Dosage Forms. Journal of Pharmacy and Applied Sciences| January-June. 2015;2(1):21.
4. Gandhi N, Ezhava S. Stability-indicating analytical method development using quality by design (QbD) approach for simultaneous estimation of budesonide and levosalbutamol. Journal of AOAC International. 2022 May 1;105(3):665-74.
5. Bharti P, Sachan N, Chandra P, SM S. Development and validation of selective UV spectrophotometric analytical method for budesonide pure sample. Journal of Applied Pharmaceutical Science. 2011 Sep 30(Issue):158-61.
6. Madankar VS, Jadhav SD, Londhe NB. Spectrophotometric methods development and validation of budesonide in bulk and marketed formulation. J Emer Techno Innov Res. 2018;5:438-46
7. Naikwade SR, Bajaj AN. Development of a validated specific HPLC method for budesonide and characterization of its alkali degradation product. Can J Anal Sci Spect. 2008 Jan 1;53:113-22.
8. NOVEL AND VALIDATED SPECTROPHOTOMETRIC DETERMINATION OF BUDESONIDE FROM BULK AND TABLETS USING MIXED HYDROTROPIC SOLUBILIZATION TECHNIQUE.
9. Patel NK, Koradia SK. Development and Validation of stability indicating RP-HPLC method for the simultaneous estimation of Beclomethasone dipropionate and Formoterol fumarate in their combined pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2016;6(2):83-90.
10. Dave HN, Makwana AG, Suhagia BN. Validated reversed phase high performance liquid chromatographic method for determination of three novel steroids in bulk and pressurized metered dose commer cial preparations using a common mobile phase. Int J Appl Sci Eng. 2013 Jun 1;11(2):125-35.